KRAS and carcinoma: For example, miR-31 and miR-135b have both been implicated in the serrated neoplasia pathway—particularly in lesions with high microsatellite instability—high and BRAF mutations—whereas miR-143 and miR-145 are commonly associated with AD–carcinoma sequences and KRAS or APC mutations [26].